PIPRACIL Drug Patent Profile
✉ Email this page to a colleague
When do Pipracil patents expire, and what generic alternatives are available?
Pipracil is a drug marketed by Wyeth Pharms Inc and is included in two NDAs.
The generic ingredient in PIPRACIL is piperacillin sodium. There are sixteen drug master file entries for this compound. Additional details are available on the piperacillin sodium profile page.
Summary for PIPRACIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Patent Applications: | 5,189 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PIPRACIL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PIPRACIL
US Patents and Regulatory Information for PIPRACIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Pharms Inc | PIPRACIL | piperacillin sodium | INJECTABLE;INJECTION | 062750-001 | Oct 13, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Pharms Inc | PIPRACIL | piperacillin sodium | INJECTABLE;INJECTION | 050545-006 | Sep 30, 1985 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Pharms Inc | PIPRACIL | piperacillin sodium | INJECTABLE;INJECTION | 050545-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Pharms Inc | PIPRACIL | piperacillin sodium | INJECTABLE;INJECTION | 050545-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Pharms Inc | PIPRACIL | piperacillin sodium | INJECTABLE;INJECTION | 062750-002 | Oct 13, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |